In fact, it is now recognized that ERK/MAPK and IRS-1/PI3K/AKT/GSK-3β, the major IGF-1R signaling transduction pathways, are involved in IGF-1-mediated EMT activation in BC. This evidence concerns the gene IGF1R and breast cancer.